Cryo-Cell International, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)

6 Months Ended

May 31, 2018

Variables used to determine the fair value of the options granted for the three and six months ended May 31, 2018 are as follows:


	Three Months Ended May 31, 2018			Six Months Ended May 31, 2018
Weighted average values:
Expected dividends		0	%		0	%
Expected volatility		50.8	%		50.8	%
Risk free interest rate		2.67	%		2.67	%
Expected life		5 years			5 years

Service-Based Vesting Condition Options [Member]

Stock Option Activity

Stock option activity for options with only service-based vesting conditions for the six months ended May 31, 2018, was as follows:


	Options			Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (Years)		Aggregate Intrinsic Value
Outstanding at November 30, 2017		1,026,979		$	2.50		4.48	$	5,706,107
Granted		51,636			7.85				80
Exercised		(2,250	)		2.19				12,815
Expired/forfeited		(11,000	)		2.10				59,380

Outstanding at May 31, 2018		1,065,365		$	2.77		4.22	$	5,059,743

Exercisable at May 31, 2018		1,016,358		$	2.57		4.14	$	5,018,648

Significant Option Groups Outstanding and Exercisable Option and its Price and Contractual Life

Significant option groups outstanding and exercisable at May 31, 2018 and related price and contractual life information are as follows:


	Outstanding						Exercisable
Range of Exercise Prices	Outstanding		Weighted Average Remaining Contractual Life (Years)		Weighted Average Exercise Price		Outstanding		Weighted Average Exercise Price
$1.01 to $2.00		422,500		3.43	$	1.73		422,500	$	1.73
$2.01 to $3.00		339,000		2.33	$	2.70		339,000	$	2.70
$3.01 to $4.00		227,229		7.67	$	3.18		218,896	$	3.18
$6.01 to $7.00		25,000		8.84	$	6.95		18,747	$	7.00
$7.01 to $8.00		51,636		5.58	$	7.85		17,215	$	7.85

		1,065,365		4.22	$	2.77		1,016,358	$	2.57

Summary of Non-Vested Options

A summary of the status of the Company’s non-vested options as of May 31, 2018, and changes during the six months ended May 31, 2018, is presented below:


	Options			Weighted Average Grant-Date Fair Value
Non-vested at November 30, 2017		39,168		$	2.41
Granted		51,636			3.23
Vested		(41,797	)		2.77
Forfeited		—			—

Non-vested at May 31, 2018		49,007		$	2.96